<DOC>
	<DOCNO>NCT01834157</DOCNO>
	<brief_summary>Systemic sclerosis ( SSc ) orphan , multiorgan disease affect connective tissue skin several internal organ . Beside skin involvement , digital ulcer , tendinitis , calcinosis flexion contracture , presence hand arthritis major contributor impairment hand function systemic sclerosis . Several immunomodulatory drug use rheumatic disease ( include methotrexate , leflunomide , azathioprine , mycophenolate mofetil low-dose corticosteroid ) potentially improve arthritis consequently hand function systemic sclerosis . For assessment arthritis , CDAI ( clinical disease activity index ) validate rheumatoid arthritis , may useful SSc-related arthritis , . This observational trial part collaborative project `` DeSScipher '' , one five observational trial decipher optimal management systemic sclerosis . Aim observational trial : - investigate efficacy safety different treatment hand dysfunction systemic sclerosis patient hand arthritis - validate CDAI arthritis systemic sclerosis .</brief_summary>
	<brief_title>Improvement Hand Dysfunction Arthritis Systemic Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<criteria>Juvenile adult Systemic sclerosis patient , diagnosis accord ACR/EULAR adult SSc criterion PRES/ACR/EULAR juvenile SSc criterion respectively Clinical sign arthritis ( define â‰¥2 tender swollen joint ) Presence significant , long stand articular pain due cause autoimmune disease Presence hand disability cause , autoimmune disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>